Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jun 9;2(7):621-2.
doi: 10.1016/j.ebiom.2015.06.002. eCollection 2015 Jul.

Can we be SMaRT-er in our approach to cancer therapy?

Christina Gruber  1 , Josefina Piñón Hofbauer  1 , Johann W Bauer  1
Affiliations

Can we be SMaRT-er in our approach to cancer therapy?

Christina Gruber et al. EBioMedicine. .
No abstract available

PubMed Disclaimer

References

    1. Chao H., Mansfield S.G., Bartel R.C. Phenotype correction of hemophilia A mice by spliceosome-mediated RNA trans-splicing. Nat. Med. 2003;9:1015–1019. - PubMed
    1. Gruber C., Koller U., Murauer E.M. The design and optimization of RNA trans-splicing molecules for skin cancer therapy. Mol. Oncol. 2013;7:1056–1068. - PMC - PubMed
    1. He X., Liu F., Yan J. Trans-splicing repair of mutant p53 suppresses the growth of hepatocellular carcinoma cells in vitro and in vivo. Sci. Rep. 2015;5:8705. - PMC - PubMed
    1. Koller U., Hainzl S., Kocher T. Trans-splicing improvement by the combined application of antisense strategies. Int. J. Mol. Sci. 2015;16:1179–1191. - PMC - PubMed
    1. Monjaret F., Bourg N., Suel L. Cis-splicing and translation of the pre-trans-splicing molecule combine with efficiency in spliceosome-mediated RNA trans-splicing. Mol. Ther. 2014;22:1176–1187. - PMC - PubMed

Publication types

LinkOut - more resources